Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 120.93 USD -0.12% Market Closed
Market Cap: 17.7B USD

Intrinsic Value

The intrinsic value of one BIIB stock under the Base Case scenario is 196.11 USD. Compared to the current market price of 120.93 USD, Biogen Inc is Undervalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIIB Intrinsic Value
196.11 USD
Undervaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Biogen Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
BIIB
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BIIB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on Biogen Inc?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Biogen Inc’s research
View All Researches
Biogen Inc
NASDAQ:BIIB
US
Biotechnology
Market Cap
17.6B USD
IPO
Sep 17, 1991
US
Biotechnology
Market Cap
17.6B USD
IPO
Sep 17, 1991
Price
$false
EPS
$false
AI Assistant
AI Assistant
Ask me anything about Biogen Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biogen Inc

Current Assets 7.5B
Cash & Short-Term Investments 2.4B
Receivables 1.9B
Other Current Assets 3.2B
Non-Current Assets 20.6B
Long-Term Investments 560.5m
PP&E 3.5B
Intangibles 16.2B
Other Non-Current Assets 324.2m
Efficiency

Free Cash Flow Analysis
Biogen Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biogen Inc

Revenue
9.7B USD
Cost of Revenue
-2.2B USD
Gross Profit
7.5B USD
Operating Expenses
-4.8B USD
Operating Income
2.7B USD
Other Expenses
-1B USD
Net Income
1.6B USD
Fundamental Scores

BIIB Profitability Score
Profitability Due Diligence

Biogen Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive Net Income
58/100
Profitability
Score

Biogen Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

BIIB Solvency Score
Solvency Due Diligence

Biogen Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
60/100
Solvency
Score

Biogen Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIIB Price Targets Summary
Biogen Inc

Wall Street analysts forecast BIIB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIIB is 193.01 USD with a low forecast of 122.21 USD and a high forecast of 359.1 USD.

Lowest
Price Target
122.21 USD
1% Upside
Average
Price Target
193.01 USD
60% Upside
Highest
Price Target
359.1 USD
197% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BIIB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BIIB Insider Trading
Buy and sell transactions by insiders

BIIB News

Other Videos
What is the Intrinsic Value of one BIIB stock?

The intrinsic value of one BIIB stock under the Base Case scenario is 196.11 USD.

Is BIIB stock undervalued or overvalued?

Compared to the current market price of 120.93 USD, Biogen Inc is Undervalued by 38%.

Back to Top